Connect your AI

Omnicell OMCL Remainder of Fiscal Year 2024

Remainder of Fiscal Year 2024 at other companies

Cardinal HealthCAH

——

ICU MedicalICUI

——

Claritev CorporationCTEV

——

Nutex Health Inc.NUTX

——

SolventumSOLV

——

Medline, Inc. MDLN

——

Other financials

Income statement

Revenue$309.9M+14.9%

Gross profit$140.4M+26.5%

Operating income$16.9M+245%

Net income$11.4M+262%

EPS (diluted)$0.25+267%

Balance sheet

Cash & equivalents$291.0M-29.8%

Total debt$34.3M-23.1%

Total equity$1.3B0.0%

Total assets$2.0B-6.8%

Cash flow

Operating cash flow$54.5M+110%

CapEx$12.4M+11.3%

Free cash flow$42.1M+185%

Valuation

Market cap$1.8B+36.9%

Enterprise value$1.54B+63.4%

P/E116.5×—

P/S1.5×+0.3×

Profitability

Gross margin43.5%+0.4pp

Operating margin2.7%+1.8pp

Net margin1.7%+1.1pp

FCF margin9.3%-1.7pp

Returns & leverage

Return on equity1.6%+1.1pp

Debt / equity0×0.0×

Current ratio1.5×+0.1×

Where this comes from

Reported directly by Omnicell in its filing.

Tagged under the XBRL concept us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear.

The official record: Omnicell’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Omnicell's remainder of fiscal year 2024.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Omnicell's remainder of fiscal year 2024?: Omnicell (OMCL) reported remainder of fiscal year 2024 of $10.12M in Q1 2026.
How has Omnicell's remainder of fiscal year 2024 changed year-over-year?: Omnicell's remainder of fiscal year 2024 decreased by 2.1% year-over-year, from $10.33M to $10.12M.